skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All








16 Total results for product and free and sample content found

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Scrip Titans of Pharma

16 Jun 2022

Scrip Titans of Pharma

The 2021 Titans of Pharma provides snapshot of the industry’s top 15 leaders and the businesses they oversee, with vital statistics covering the compensation of CEOs and R&D heads, median employee pay, and company performance. 

Topic Business Strategies Leadership

What Does The Pharma Industry Want From CROs?

15 Jun 2022

What Does The Pharma Industry Want From CROs?

Get exclusive insights into what senior decision makers from small to large biotech and pharma companies want from contract research organizations.

Topic Market Intelligence Business Strategies Leadership

Pharma Intelligence Apps

What Does The Pharma Industry Want From CDMOs?

13 May 2022

Pharma Intelligence

Based on a survey to over 100 of pharma’s senior decision makers, find out what organizations really want from CDMOs.

Topic Business Strategies Leadership

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

Rising Leaders 2021

27 May 2021

Rising Leaders

Gain insights into managing unexpected events, effectively communicating change, executing crisis management plans, and more. Industry experts share their insights into innovative ways to integrate teams after M&A, manage D&I initiatives, and build strong leadership for a changing workforce.

Topic Leadership

Medtech Insight: 世界の医療機器・医療技術の最新情報

10 Predictions On How Health Policy Could Change Under A Biden Presidency

By Sue Darcey 29 Nov 2020

medtech telehealth joe biden

Health policy changes that President-elect Joe Biden will likely make during his four-year term include Medicaid expansion and a greater reliance on medical science, among others, experts say.

Topic US Election 2020 Leadership Policy & Regulation

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

Bayer US Pharmaceuticals' Sebastian Guth: Designs On A New Decade

By William Looney 27 Nov 2020


Bayer’s ambitious campaign to reposition itself as a global leader in two complementary fields – health and nutrition – will face its toughest test in the US, with its highly litigious approach to product liability and a tendency to target pharmaceuticals as the source of the health system’s affordability and access problems.

Topic Business Strategies Leadership